3i, LP 13D/13G Filings for Channel Therapeutics Corporation (CHRO)

3i, LP 13D and 13G filings for Channel Therapeutics Corporation:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-11-13
4:05 pm
Sale
2024-09-3013GChannel Therapeutics Corporation
CHRO
3i, LP30,100
4.990%
-1,782decrease
(-5.59%)
Filing
2024-03-01
5:07 pm
Purchase
2024-02-2113GChannel Therapeutics Corporation
CHRO
3i, LP31,882
5.500%
31,882increase
(New Position)
Filing